Translate Bio Inc
NASDAQ:TBIO 3:59:58 PM EDT
| Market Cap (Intraday) | 1.49B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 17.99 |
| 10-Day MA | $18.75 |
| 50-Day MA | $21.07 |
| 200-Day MA | $18.61 |
Translate Bio Inc Stock, NASDAQ:TBIO
29 Hartwell Avenue, 29 Hartwell Avenue, Lexington, Massachusetts 02421
United States of America
Phone: +1.617.945.7361
Number of Employees: 122
Description
Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA.